Active ingredient
Naratriptan
8 finished FDA listings contain Naratriptan as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- NARATRIPTAN HYDROCHLORIDE
- Dosage forms
- Tablet, Tablet, Film Coated
- Routes
- Oral
- Manufacturers / labelers
- 4
- Strengths listed
- 1 mg/1 · 2.5 mg/1
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 141366
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 090381 | HIKMA | 2010-07-07 | 2 |
| ANDA 200502 | HERITAGE | 2011-02-28 | 4 |
| ANDA 091441 | ORBION PHARMS | 2012-04-30 | 2 |
Official labeling on DailyMed
- NARATRIPTAN TABLET [ASCLEMED USA INC.] · version 1 · 2026-08-12
- NARATRIPTAN TABLET, FILM COATED [BIONPHARMA INC.] · version 4 · 2026-07-01
- NARATRIPTAN TABLET [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.] · version 20 · 2025-11-17
- NARATRIPTAN TABLET [HIKMA PHARMACEUTICALS USA INC.] · version 7 · 2023-07-25
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.